| Product Name | Glecaprevir | ABT-493 | A 1282576 |
|---|---|
| CAS | 1365970-03-1 |
| Formula | C38H46F4N6O9S |
| MW | 838.87 |
| Appearance | White to off-white powder |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity | |
|---|---|---|---|---|---|
|
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible. |
|||||
| Product Name | Glecaprevir | ABT-493 | A 1282576 |
|---|---|
| CAS | 1365970-03-1 |
| Formula | C38H46F4N6O9S |
| MW | 838.87 |
| Appearance | White to off-white powder |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Glecaprevir (previously called ABT493; A1282576;ABT-493; A-1282576;Mavyret) is a novel and potent inhibitor of thehepatitis C virus nonstructural protein 3/4A protease (HCV NS3/4A) approved as anti-HCV drug in co-formulation with an HCV NS5A inhibitor pibrentasvir.